Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8659832 | Heart, Lung and Circulation | 2018 | 7 Pages |
Abstract
In this study of patients with PAH receiving parenteral treprostinil, PCWP was not associated with long-term all-cause mortality. Further studies examining prognostic indicators in patients with PAH optimised on guideline-based therapies are warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jignesh K. MD, Youlan PhD, Paul MD,